CVS
CVS Health · Healthcare
Smart money activity
Every tracked buy, add, trim, and exit on CVS by the best portfolio managers in the world. Ranked by manager quality inside each quarter.
| Portfolio manager | % portfolio |
|---|---|
Joel GreenblattElite Gotham Asset Management | 0.10% |
| Portfolio manager | % portfolio |
|---|---|
Joel GreenblattElite Gotham Asset Management | 0.10% |
Oakmark Funds | 0.10% |
| Portfolio manager | % portfolio |
|---|---|
Joel GreenblattElite Gotham Asset Management | 0.10% |
Oakmark Funds | 0.10% |
| Portfolio manager | % portfolio |
|---|---|
Joel GreenblattElite Gotham Asset Management | 0.30% |
| Portfolio manager | % portfolio |
|---|---|
Fairfax Financial | 7.80% |
Joel GreenblattElite Gotham Asset Management | 0.20% |
Lee AinslieElite Maverick Capital | 0.00% |
| Portfolio manager | % portfolio |
|---|---|
Lee AinslieElite Maverick Capital | 1.30% |
Oakmark Funds | 0.50% |
Joel GreenblattElite Gotham Asset Management | 0.40% |
| Portfolio manager | % portfolio |
|---|---|
Scion Asset Management | 0.00% |
Insider activity
SEC Form 4 filings — when CEOs, CFOs, and 10%+ owners buy or sell their own stock.
| Insider | Value |
|---|---|
Shulman Douglas H. Director | $141K |
SANSONE GUY P Director | $141K |
ROBBINS LARRY Director | $187K |
Norwalk Leslie V Director | $141K |
Mahoney Michael F Director | $169K |
KIRBY J SCOTT Director | $141K |
Gallina John E Director | $141K |
Finucane Anne A. Director | $150K |
DECOUDREAUX ALECIA A Director | $141K |
Gallina John E Director | $141K |
Mahoney Michael F Director | $169K |
AGUIRRE FERNANDO Director | $152K |
Balser Jeffrey R. Director | $200K |
KIRBY J SCOTT Director | $141K |
Norwalk Leslie V Director | $141K |
SANSONE GUY P Director | $141K |
DECOUDREAUX ALECIA A Director | $141K |
Finucane Anne A. Director | $150K |
BROWN C DAVID II Director | $150K |
Shulman Douglas H. Director | $141K |
ROBBINS LARRY Director | $187K |
Balser Jeffrey R. Director | $200K |
BROWN C DAVID II Director | $150K |
AGUIRRE FERNANDO Director | $152K |
Mandadi Tilak EVP, Chief Exp & Tech Officer | $6.23M |
Mandadi Tilak EVP, Chief Exp & Tech Officer | $6.23M |
Latest news
Recent headlines for CVS.
Hedge funds holding CVS
1 superinvestor hold CVS Health as a top position. Sorted by % of portfolio.
| Manager | % Portfolio |
|---|---|
Healthcare at reasonable P/E. | 5.9% |
What will you keep of every $100 in CVS dividend?
Estimates for educational purposes only. Tax rules change; consult a qualified tax professional for your specific situation. Dividend-tax treatment depends on holding period, account type (taxable vs. retirement), investor type (individual vs. pension vs. mutual fund), limitation-on-benefits tests, and other factors not modeled here.
Get alerts when they buy or sell CVS
One email per 13F filing — you'll know within hours if any tracked manager moves on CVS.
Related smart-money signals
Frequently asked questions
Who owns CVS?
1 tracked superinvestors hold CVS Health (CVS) as a top position based on the latest SEC 13F filings. Largest tracked holder: Prem Watsa at 5.9% of portfolio. Full ranking by % of portfolio shown in the table below.
How many hedge funds hold CVS?
1 of HoldLens's tracked superinvestors hold CVS according to the latest SEC 13F filings. The sum of conviction across those holders is 6% (sum of each manager's % of portfolio in CVS).
Who is the biggest hedge-fund holder of CVS?
Among HoldLens's tracked superinvestors, Prem Watsa holds the largest CVS position at 5.9% of portfolio. Healthcare at reasonable P/E.
What sector is CVS?
CVS Health (CVS) is classified as Healthcare. Smart-money activity, insider trades (SEC Form 4), buybacks, short interest, congressional trades, and ETF ownership for CVS are all aggregated on this page.
Data sourced from SEC 13F filings. CVS ownership reflects publicly disclosed long positions only. Not investment advice.